TEMPOROMANDIBULAR DISORDERS: DEVELOPMENTAL MECHANISMS, CLINICAL COURSE, DIAGNOSIS AND CONTEMPORARY MANAGEMENT — A NARRATIVE REVIEW OF CURRENT EVIDENCE
Keywords:
temporomandibular disorders; temporomandibular joint; osteoarthritis; myalgia; arthralgia; disc displacement; central sensitisation; DC/TMD; magnetic resonance imaging; cone-beam computed tomography; biopsychosocial model; orofacial painAbstract
Background. Temporomandibular disorders (TMDs) comprise a heterogeneous group of painful and functional conditions of the temporomandibular joint (TMJ), the masticatory muscles and functionally associated orofacial structures, classified under ICD-10 code M26.6. Over the past two decades the conceptual model of TMD has shifted from an occlusion-centred mechanical paradigm to a multifactorial biopsychosocial framework.
Aim. To synthesise current evidence on the aetiology and molecular pathogenesis of TMDs, to characterise the clinical course of their principal phenotypes, to appraise the performance of contemporary diagnostic instruments, and to systematise evidence-based treatment principles.
Methods. A narrative review with a structured literature search was performed in PubMed/MEDLINE, Scopus and the Cochrane Library for records published between January 2005 and May 2026. Priority was given to systematic reviews, meta-analyses, network meta-analyses and clinical practice guidelines. Quantitative estimates were extracted and tabulated without re-analysis.
Results. Pooled global prevalence estimates ranged from 29.5% to 34.0% across recent meta-analyses, with a consistent female predominance (36.7% vs 26.7%). Intra-articular disorders affected 31.1% of adults, disc displacement with reduction being the most frequent subtype (25.9%). Cohort evidence identified female sex, depressive and anxiety symptoms, perceived stress, poor sleep quality, obstructive sleep apnoea, comorbid pain conditions, heightened pain sensitivity and trauma as risk factors for TMD onset. In TMJ osteoarthritis, mechanical overload activates IL-1β-, TNF-α- and IL-6-driven signalling through NF-κB and MAPK cascades, upregulating MMP-3, MMP-9, MMP-13, ADAMTS-4 and ADAMTS-5, degrading the extracellular matrix and driving subchondral bone remodelling, peripheral nociceptor sensitisation and central sensitisation. DC/TMD Axis I criteria showed high accuracy for pain-related diagnoses (myalgia, sensitivity 0.90, specificity 0.99; arthralgia, 0.89/0.98) but limited sensitivity for intra-articular diagnoses (disc displacement with reduction, 0.34; degenerative joint disease, 0.55). A network meta-analysis of 153 trials and 8,713 participants found the largest pain reductions with cognitive behavioural therapy combined with biofeedback or relaxation (mean difference −2.62 cm on a 10 cm visual analogue scale) and therapist-assisted jaw mobilisation (−2.57 cm), both with moderate certainty.
Conclusion. TMDs are best understood as multifactorial disorders in which mechanical, inflammatory, neurophysiological and psychosocial mechanisms interact. Management should begin with reversible, education-based and exercise-based interventions; irreversible occlusal modification, discectomy and the combination of NSAIDs with opioids are subject to strong recommendations against. The governing clinical principle is to treat the patient rather than the joint.
References
1.Suvinen TI, Reade PC, Kemppainen P, Könönen M, Dworkin SF. Review of aetiological concepts of temporomandibular pain disorders: towards a biopsychosocial model for integration of physical disorder factors with psychological and psychosocial illness impact factors. Eur J Pain. 2005;9(6):613–33. doi:10.1016/j.ejpain.2005.01.012
2.Ohrbach R, Dworkin SF. The evolution of TMD diagnosis: past, present, future. J Dent Res. 2016;95(10):1093–101. doi:10.1177/0022034516653922
3.International Classification of Orofacial Pain, 1st edition (ICOP). Cephalalgia. 2020;40(2):129–221. doi:10.1177/0333102419893823
4.Zieliński G, Pająk-Zielińska B, Ginszt M. A meta-analysis of the global prevalence of temporomandibular disorders. J Clin Med. 2024;13(5):1365. doi:10.3390/jcm13051365
5.Alqutaibi AY, Alassaf MS, Radi MA, et al. Global prevalence of temporomandibular disorders: a systematic review and meta-analysis. J Oral Facial Pain Headache. 2025;39(2):48–65. doi:10.22514/jofph.2025.025
6.Ohrbach R, Dworkin SF. AAPT diagnostic criteria for chronic painful temporomandibular disorders. J Pain. 2019;20(11):1276–92. doi:10.1016/j.jpain.2019.04.003
7.Sharma S, Breckons M, Brönnimann Lambelet B, et al. Challenges in the clinical implementation of a biopsychosocial model for assessment and management of orofacial pain. J Oral Rehabil. 2020;47(1):87–100. doi:10.1111/joor.12871
8.Da-Cas CD, Valesan LF, do Nascimento LP, et al. Risk factors for temporomandibular disorders: a systematic review of cohort studies. Oral Surg Oral Med Oral Pathol Oral Radiol. 2024;138(4):502–15. doi:10.1016/j.oooo.2024.06.007
9.Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for clinical and research applications: recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache. 2014;28(1):6–27. doi:10.11607/jop.1151
10.Lu K, Ma F, Yi D, Yu H, Tong L, Chen D. Molecular signaling in temporomandibular joint osteoarthritis. J Orthop Translat. 2022;32:21–7. doi:10.1016/j.jot.2021.07.001
11.Yao L, Sadeghirad B, Li M, et al. Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials. BMJ. 2023;383:e076226. doi:10.1136/bmj-2023-076226
12.Valesan LF, Da-Cas CD, Réus JC, et al. Prevalence of temporomandibular joint disorders: a systematic review and meta-analysis. Clin Oral Investig. 2021;25(2):441–53. doi:10.1007/s00784-020-03710-w
13.Lobbezoo F, Ahlberg J, Raphael KG, et al. International consensus on the assessment of bruxism: report of a work in progress. J Oral Rehabil. 2018;45(11):837–44. doi:10.1111/joor.12663
14.Warzocha J, Gadomska-Krasny J, Mrowiec J. Etiologic factors of temporomandibular disorders: a systematic review of literature containing diagnostic criteria for TMD. Healthcare (Basel). 2024;12(5):575. doi:10.3390/healthcare12050575
15.Zhang J, Mu XT, Zhang X, Li CY. Potential pathological and molecular mechanisms of temporomandibular joint osteoarthritis. J Dent Sci. 2023;18(3):959–71. doi:10.1016/j.jds.2023.04.002
16.Cardoneanu A, Macovei LA, Burlui AM, et al. Temporomandibular joint osteoarthritis: pathogenic mechanisms involving the cartilage and subchondral bone, and potential therapeutic strategies for joint regeneration. Int J Mol Sci. 2023;24(1):171. doi:10.3390/ijms24010171
17.Busse JW, Casassus R, Carrasco-Labra A, et al. Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline. BMJ. 2023;383:e076227. doi:10.1136/bmj-2023-076227




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal